Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Rogosin Institute

About this trial

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males or females

18 years of age and older

Willing and able to provide informed consent

Previously had a kidney biopsy and the tissue is not stored in this biorepository; or

Disqualifiers

None

Trial population

Subjects will be recruited from The Rogosin Institute, NewYork Presbyterian Hospital and affiliated institutions.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 3 trial groups
Group A: Native, Renal Tissue Preservation Group
Group B: Native, Non-tissue Preservation Group
Group C: Transplant Nephropathy Group

Trial outcomes

Primary outcomes

1

Change in disease progression

Time frame
Up to 10 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Rogosin Institute

Lead sponsor

New York Presbyterian Hospital

Collaborator

Weill Medical College of Cornell University

Collaborator